Literature DB >> 18829701

Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium.

Javier Inserte1, Ignasi Barba, Víctor Hernando, David Garcia-Dorado.   

Abstract

AIMS: Indirect data suggest that delayed recovery of intracellular pH (pHi) during reperfusion is involved in postconditioning protection, and calpain activity has been shown to be pH-dependent. We sought to characterize the effect of ischaemic postconditioning on pHi recovery during reperfusion and on calpain-dependent proteolysis, an important mechanism of myocardial reperfusion injury. METHODS AND
RESULTS: Isolated Sprague-Dawley rat hearts were submitted to 40 min of ischaemia and different reperfusion protocols of postconditioning and acidosis. pHi was monitored by (31)P-NMR spectroscopy. Myocardial cell death was determined by lactate dehydrogenase (LDH) and triphenyltetrazolium staining, and calpain activity by western blot measurement of alpha-fodrin degradation. In control hearts, pHi recovered within 1.5 +/- 0.24 min of reperfusion. Postconditioning with 6 cycles of 10 s ischaemia-reperfusion delayed pHi recovery slightly to 2.5 +/- 0.2 min and failed to prevent calpain-mediated alpha-fodrin degradation or to elicit protection. Lowering perfusion flow to 50% during reperfusion cycles or shortening the cycles (12 cycles of 5 s ischemia-reperfusion) resulted in a further delay in pHi recovery (4.1 +/- 0.2 and 3.5 +/- 0.3 min, respectively), attenuated alpha-fodrin proteolysis, improved functional recovery, and reduced LDH release (47 and 38%, respectively, P < 0.001) and infarct size (36 and 32%, respectively, P < 0.001). This cardioprotection was identical to that produced by lowering the pH of the perfusion buffer to 6.4 during the first 2 min of reperfusion or by calpain inhibition with MDL-28170.
CONCLUSION: These results provide direct evidence that postconditioning protection depends on prolongation of intracellular acidosis during reperfusion and indicate that inhibited calpain activity could contribute to this protection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829701     DOI: 10.1093/cvr/cvn260

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  24 in total

1.  Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.

Authors:  Weiwei Shi; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2012-02-09       Impact factor: 10.787

Review 2.  Mitochondrial Ca2+ and regulation of the permeability transition pore.

Authors:  Stephen Hurst; Jan Hoek; Shey-Shing Sheu
Journal:  J Bioenerg Biomembr       Date:  2016-08-06       Impact factor: 2.945

Review 3.  The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.

Authors:  Javier Inserte; David Garcia-Dorado
Journal:  Br J Pharmacol       Date:  2015-03-16       Impact factor: 8.739

Review 4.  Chasing cardiac physiology and pathology down the CaMKII cascade.

Authors:  Alicia Mattiazzi; Rosana A Bassani; Ariel L Escobar; Julieta Palomeque; Carlos A Valverde; Martín Vila Petroff; Donald M Bers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

5.  Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion.

Authors:  D Pravdic; Y Mio; F Sedlic; P F Pratt; D C Warltier; Z J Bosnjak; M Bienengraeber
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

6.  Ischemic post-conditioning to counteract intestinal ischemia/reperfusion injury.

Authors:  Yan-Fang Guan; Timothy A Pritts; Marshall H Montrose
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

7.  Protection of the ischemic myocardium during the reperfusion: between hope and reality.

Authors:  Jean Chrisostome Bopassa
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

8.  Ca2+ Sparks and Ca2+ waves are the subcellular events underlying Ca2+ overload during ischemia and reperfusion in perfused intact hearts.

Authors:  Alicia Mattiazzi; Mariana Argenziano; Yuriana Aguilar-Sanchez; Gabriela Mazzocchi; Ariel L Escobar
Journal:  J Mol Cell Cardiol       Date:  2014-10-28       Impact factor: 5.000

Review 9.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

10.  A novel neuroprotective strategy for ischemic stroke: transient mild acidosis treatment by CO2 inhalation at reperfusion.

Authors:  Yan-Ying Fan; Zhe Shen; Ping He; Lei Jiang; Wei-wei Hou; Yao Shen; Xiang-Nan Zhang; Wei-Wei Hu; Zhong Chen
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.